- TIGERTRIEVER XL is the largest stentriever available, designed to safely 
remove clots from intracranial vessels up to 9mm in diameter

Rapid Medical [http://www.rapid-medical.com/], a company focused on the 
development of next generation neurovascular devices, has announced that it 
received CE Mark for TIGERTRIEVER XL. In addition, the first patients have been 
treated successfully with the device. 

The TIGERTRIEVER family of stentrievers are the first-ever adjustable, fully 
visible clot retrievers designed to treat ischemic stroke. Thousands of 
patients have been successfully treated with TIGERTRIEVER to date. TIGERTRIEVER 
XL is the newest addition to the portfolio. Its adjustable diameter can conform 
to any vessel diameter up to 9mm and at 53mm in length, it is the largest and 
the longest stentriever available. Although significantly larger than other 
similar devices on the market, it is easily delivered via a standard 
microcatheter with an internal diameter of 0.021".

"TIGERTRIEVER XL is a very important addition to the ischemic stroke market," 
said Dr. Sebastian Fischer, a senior Interventional Neuroradiologist at Bochum 
University Hospital, Germany. "For the first time, we have a tool that can be 
adjusted to these dimensions and is dedicated to retrieve large clot loads. 
This is an important addition to our current tool set, since it can potentially 
reduce the number of passes required to remove large stroke-causing clots, for 
example, in the internal carotid artery."

Ronen Eckhouse, CEO of Rapid Medical commented on the first clinical experience 
with TIGERTRIEVER XL: "TIGERTRIEVER XL is another example of our powerful 
technology that adjusts to the vessel diameter for full clot removal in the 
treatment large vessel occlusion. TIGERTRIEVER XL compliments TIGERTRIEVER 13, 
the smallest stentriever available today, and the only stentriever indicated 
for distal vessel occlusion. The TIGERTRIEVER portfolio now allows surgeons to 
treat ischemic stroke in the majority of vessels where it occurs." 

About Rapid Medical

Rapid Medical is developing game-changing devices for neurovascular treatments. 
Rapid Medical is the maker of TIGERTRIEVER(TM) and COMANECI(TM), the first-ever 
adjustable remodeling mesh. TIGERTRIEVER and COMANECI are CE marked for use in 
Europe and COMANECI is also FDA approved. More information is available at 
www.rapid-medical.com

Contact:
Ronen Eckhouse
+972-72-2503331 
ronen@rapid-medical.com

Source: Rapid Medical